195.8K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 33,911 | 0 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 33,911 | 214,145 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.27 per share. | 15 Feb 2025 | 15,203 | 198,942 (0%) | 0% | 13.3 | 201,744 | Common Stock |
| Kimberley E. Honeysett | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 10,432 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 0 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.27 per share. | 15 Feb 2025 | 2,835 | 7,597 (0%) | 0% | 13.3 | 37,620 | Common Stock |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 71,003 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.27 per share. | 15 Feb 2025 | 2,835 | 68,168 (0%) | 0% | 13.3 | 37,620 | Common Stock |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 0 | - | - | Restricted Stock Units | |
| Andrew J. Hartmann | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 0 | - | - | Restricted Stock Units | |
| Andrew J. Hartmann | SVP and GM, Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.27 per share. | 15 Feb 2025 | 2,720 | 27,219 (0%) | 0% | 13.3 | 36,094 | Common Stock |
| Andrew J. Hartmann | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 5,762 | 29,939 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 34,172 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 0 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,123 | 12,123 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 18,294 (0%) | 0% | - | Common Stock | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,123 | 12,123 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 0 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 42,315 (0%) | 0% | - | Common Stock | |
| Walter M. Rosebrough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 14,695 | 14,695 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 0 | - | - | Deferred Stock Units | |
| Kathleen Lynn Bardwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,619 | 3,619 (0%) | 0% | - | Common Stock | |
| Kathleen Lynn Bardwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,123 | 12,123 | - | - | Deferred Stock Units | |
| Kathleen Lynn Bardwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,619 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 25,052 (0%) | 0% | - | Common Stock | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,123 | 12,123 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 33,711 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 12,123 | 12,123 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,573 | 0 | - | - | Deferred Stock Units | |
| Mark Jonaitis S. | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 1,613 | 1,613 | - | - | Performance Stock Units | |
| Andrew Hartmann | SVP and GM, Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 1,613 | 1,613 | - | - | Performance Stock Units | |
| Maheshwari Shubham | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 2,839 | 2,839 | - | - | Performance Stock Units | |
| Honeysett Kimberley E. | SVP and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 1,742 | 1,742 | - | - | Performance Stock Units | |
| Sanyal Sunny S. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 9,681 | 9,681 | - | - | Performance Stock Units | |
| L. Karen Aranki | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 1,355 | 1,355 | - | - | Performance Stock Units | |
| Hartmann Andrew | SVP and GM, Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Sunny Sanyal S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 40,382 | 197,962 (0%) | 0% | - | Common Stock | |
| E. Honeysett Kimberley | SVP and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 10 Dec 2024 | 3,137 | 4,670 (0%) | 0% | 15.5 | 48,467 | Common Stock |
| Sanyal S. Sunny | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 10 Dec 2024 | 17,728 | 180,234 (0%) | 0% | 15.5 | 273,898 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 25,307 | 25,307 | - | - | Restricted Stock Units | |
| Mark Jonaitis S. | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 6,523 | 68,105 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP and GM, Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 10 Dec 2024 | 2,734 | 24,177 (0%) | 0% | 15.4 | 42,240 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 86,181 | 86,181 | - | - | Restricted Stock Units | |
| Hartmann Andrew | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 6,523 | 6,523 | - | - | Restricted Stock Units | |
| Jonaitis Mark S. | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 6,523 | 6,523 | - | - | Restricted Stock Units | |
| E. Honeysett Kimberley | SVP and CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 15,533 | 15,533 | - | - | Restricted Stock Units | |
| Maheshwari Shubham | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 10 Dec 2024 | 2,460 | 86,218 (0%) | 0% | 15.5 | 38,007 | Common Stock |
| Maheshwari Shubham | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 9,878 | 9,878 | - | - | Restricted Stock Units | |
| Aranki Karen L. | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 12,071 | 12,071 | - | - | Restricted Stock Units | |
| Mark Jonaitis S. | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 10 Dec 2024 | 2,864 | 65,241 (0%) | 0% | 15.5 | 44,249 | Common Stock |
| Sunny Sanyal S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 40,382 | 40,383 | - | - | Restricted Stock Units | |
| S. Mark Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 6,523 | 26,911 (0%) | 0% | - | Common Stock | |
| Maheshwari Shubham | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 9,878 | 88,678 (0%) | 0% | - | Common Stock | |
| Kimberley Honeysett E. | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 7,144 | 7,145 | - | - | Restricted Stock Units | |
| Honeysett E. Kimberley | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 7,144 | 7,807 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and CLO | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 20 Aug 2024 | 2,578 | 275 (0%) | 0% | 12.5 | 32,302 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 30,315 | 86,378 (0%) | 0% | - | Common Stock | |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 30,315 | 0 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.58 per share. | 15 Aug 2024 | 7,579 | 78,799 (0%) | 0% | 12.6 | 95,344 | Common Stock |
| Karen L. Aranki | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 7,949 | 7,949 | - | - | Restricted Stock Units | |
| Karen L. Aranki | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 17,094 | 17,094 | - | - | Non-Qualified Stock Option (right to buy) | |
| Shubham Maheshwari | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 12 Aug 2024 | 10,000 | 56,063 (0%) | 0% | 10.8 | 108,200 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.98 per share. | 09 Aug 2024 | 9,007 | 46,063 (0%) | 0% | 11.0 | 98,897 | Common Stock |
| Kimberley E. Honeysett | SVP and CLO | Sale of securities on an exchange or to another person at price $ 17.37 per share. | 15 Mar 2024 | 2,860 | 2,853 (0%) | 0% | 17.4 | 49,678 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 30,223 | 0 | - | - | Restricted Stock Units | |
| Honeysett E. Kimberley | SVP and CLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 2,508 | 5,438 (0%) | 0% | 17.4 | 43,639 | Common Stock |
| Andrew Hartmann | SVP and GM, Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 2,429 | 20,388 (0%) | 0% | 17.4 | 42,265 | Common Stock |
| Hartmann Andrew | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 5,135 | 22,817 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 2,411 | 60,305 (0%) | 0% | 17.4 | 41,951 | Common Stock |
| E. Honeysett Kimberley | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 5,086 | 7,946 (0%) | 0% | - | Common Stock | |
| Sanyal Sunny S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 30,223 | 169,824 (0%) | 0% | - | Common Stock | |
| Sunny Sanyal S. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 15 Feb 2024 | 13,520 | 156,304 (0%) | 0% | 17.4 | 235,248 | Common Stock |
| Kimberley Honeysett E. | SVP and CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 5,086 | 0 | - | - | Restricted Stock Units | |
| Mark Jonaitis S. | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,890 | 62,716 (0%) | 0% | - | Common Stock | |
| Hartmann Andrew | SVP and GM, Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 5,135 | 0 | - | - | Restricted Stock Units | |
| S. Mark Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,890 | 0 | - | - | Restricted Stock Units | |
| Rosebrough Walter M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 35,742 (0%) | 0% | - | Common Stock | |
| Jocelyn Chertoff D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 9,643 | 9,643 | - | - | Deferred Stock Units | |
| E. Timothy Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 0 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 9,643 | 9,643 | - | - | Deferred Stock Units | |
| Chertoff Jocelyn D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 27,138 (0%) | 0% | - | Common Stock | |
| K. Jay Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 0 | - | - | Deferred Stock Units | |
| Lynn Kathleen Bardwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 9,643 | 9,643 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 0 | - | - | Deferred Stock Units | |
| Kunkel K. Jay | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 18,479 (0%) | 0% | - | Common Stock | |
| Rosebrough Walter M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 0 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 0 | - | - | Deferred Stock Units | |
| Rosebrough Walter M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 11,689 | 11,689 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 9,643 | 9,643 | - | - | Deferred Stock Units | |
| E. Timothy Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 11,721 (0%) | 0% | - | Common Stock | |
| A. Tsingos Christine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 6,881 | 27,599 (0%) | 0% | - | Common Stock | |
| Christine Tsingos A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 9,643 | 9,643 | - | - | Deferred Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 15,871 | 31,742 | - | - | Restricted Stock Units | |
| Honeysett Kimberley E. | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 5,108 | 5,108 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 7,062 | 37,546 (0%) | 0% | - | Common Stock | |
| S. Mark Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 4,664 | 59,879 (0%) | 0% | - | Common Stock | |
| E. Honeysett Kimberley | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 10 Dec 2023 | 2,248 | 2,860 (0%) | 0% | 19.7 | 44,263 | Common Stock |
| Jonaitis S. Mark | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 10 Dec 2023 | 2,053 | 57,826 (0%) | 0% | 19.7 | 40,424 | Common Stock |
| Sanyal S. Sunny | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 95,226 | 95,226 | - | - | Restricted Stock Units | |
| Maheshwari Shubham | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 27,932 | 27,932 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 15,871 | 31,742 | - | - | Restricted Stock Units | |
| Honeysett Kimberley E. | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 5,108 | 5,108 (0%) | 0% | - | Common Stock | |
| Sunny Sanyal S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 26,652 | 151,328 (0%) | 0% | - | Common Stock | |
| Sunny Sanyal S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 26,652 | 26,652 | - | - | Restricted Stock Units | |
| Sanyal S. Sunny | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 10 Dec 2023 | 11,727 | 139,601 (0%) | 0% | 19.7 | 230,905 | Common Stock |
| Hartmann Andrew | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 4,664 | 4,664 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 10 Dec 2023 | 1,959 | 17,682 (0%) | 0% | 19.7 | 38,573 | Common Stock |
| Maheshwari Shubham | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 7,062 | 7,063 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 4,664 | 19,641 (0%) | 0% | - | Common Stock | |
| E. Kimberley Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 17,140 | 17,140 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2023 | 4,664 | 4,664 | - | - | Restricted Stock Units | |
| Maheshwari Shubham | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 10 Dec 2023 | 1,766 | 35,780 (0%) | 0% | 19.7 | 34,773 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 23.20 per share. | 16 Jun 2023 | 2,909 | 5,913 (0%) | 0% | 23.2 | 67,489 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,689 | 3,689 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. | 15 May 2023 | 919 | 30,483 (0%) | 0% | 22.3 | 20,512 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,689 | 31,402 (0%) | 0% | - | Common Stock | |
| Jay K. Kunkel | Director | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 08 May 2023 | 9,120 | 11,598 (0%) | 0% | 21.9 | 199,728 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 33,911 | 142,162 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 33,911 | 33,911 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 8,374 | 0 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 15 Feb 2023 | 18,874 | 123,288 (0%) | 0% | 18.8 | 355,209 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 8,374 | 108,251 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 12,050 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 5,762 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,397 | 0 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 15 Feb 2023 | 3,480 | 8,570 (0%) | 0% | 18.8 | 65,494 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,397 | 6,289 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,354 | 51,742 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 57,503 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 15 Feb 2023 | 3,461 | 54,042 (0%) | 0% | 18.8 | 65,136 | Common Stock |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,354 | 0 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 5,762 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 14,103 (0%) | 0% | - | Common Stock | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 5,762 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,420 | 0 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 15 Feb 2023 | 2,851 | 11,252 (0%) | 0% | 18.8 | 53,656 | Common Stock |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,420 | 8,342 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,623 | 0 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,623 | 11,682 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 5,762 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 5,761 | 17,443 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 15 Feb 2023 | 2,466 | 14,977 (0%) | 0% | 18.8 | 46,410 | Common Stock |
| Christine A. Tsingos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,483 | 8,483 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 20,718 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 9,038 | 48,346 (0%) | 0% | - | Common Stock | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 9,038 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 9,462 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 8,471 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 9,462 | 39,308 (0%) | 0% | - | Common Stock | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 8,471 | 29,846 (0%) | 0% | - | Common Stock | |
| Timothy E. Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 4,840 | 0 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 4,840 | 4,840 (0%) | 0% | - | Common Stock | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,483 | 8,483 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 0 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 28,861 (0%) | 0% | - | Common Stock | |
| Walter M. Rosebrough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 10,339 | 10,339 | - | - | Deferred Stock Units | |
| Kathleen Lynn Bardwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,483 | 8,483 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,483 | 8,483 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 20,718 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 20,257 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 8,483 | 8,483 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 6,160 | 0 | - | - | Deferred Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 167,353 | 167,353 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 80,765 | 80,765 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 19,756 | 19,756 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 40,937 | 40,937 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 29,608 | 29,608 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 14,289 | 14,289 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 13,046 | 13,046 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 27,033 | 27,033 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 27,033 | 27,033 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 13,046 | 13,046 | - | - | Restricted Stock Units | |
| Ruediger Naumann-Etienne | Director | Sale of securities on an exchange or to another person at price $ 21.60 per share. | 24 Aug 2022 | 5,000 | 21,375 (0%) | 0% | 21.6 | 108,000 | Common Stock |
| Kathleen Lynn Bardwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 3,619 | 3,619 | - | - | Deferred Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 18 Aug 2022 | 3,028 | 4,733 (0%) | 0% | 23.5 | 71,158 | Common Stock |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 30,315 | 34,180 (0%) | 0% | - | Common Stock | |
| Shubham Maheshwari | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 30,315 | 30,315 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.31 per share. | 15 Aug 2022 | 7,640 | 26,540 (0%) | 0% | 22.3 | 170,448 | Common Stock |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 1,638 | 10,783 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 1,638 | 0 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.31 per share. | 15 Aug 2022 | 724 | 10,059 (0%) | 0% | 22.3 | 16,152 | Common Stock |
| Ruediger Naumann-Etienne | Director | Sale of securities on an exchange or to another person at price $ 22.62 per share. | 06 Jun 2022 | 5,207 | 26,375 (0%) | 0% | 22.6 | 117,782 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 8,374 | 8,374 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 30,223 | 30,223 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 8,374 | 89,092 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 7,092 | 80,718 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 30,223 | 119,315 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 7,092 | 0 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 15 Feb 2022 | 20,363 | 98,952 (0%) | 0% | 23.5 | 477,920 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,104 | 4,638 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,086 | 5,086 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,397 | 1,397 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,104 | 0 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 15 Feb 2022 | 3,578 | 7,543 (0%) | 0% | 23.5 | 83,976 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,086 | 11,121 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,397 | 6,035 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,147 | 46,707 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,354 | 48,061 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 4,890 | 52,951 (0%) | 0% | - | Common Stock | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 15 Feb 2022 | 3,488 | 49,463 (0%) | 0% | 23.5 | 81,863 | Common Stock |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,147 | 0 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,354 | 1,354 | - | - | Restricted Stock Units | |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 4,890 | 4,890 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,203 | 3,314 (0%) | 0% | - | Common Stock | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,420 | 1,420 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,203 | 0 | - | - | Restricted Stock Units | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 15 Feb 2022 | 2,946 | 6,922 (0%) | 0% | 23.5 | 69,143 | Common Stock |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,134 | 9,868 (0%) | 0% | - | Common Stock | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,420 | 4,734 (0%) | 0% | - | Common Stock | |
| Brian W. Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,134 | 5,135 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,623 | 1,623 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,134 | 5,135 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 5,134 | 12,351 (0%) | 0% | - | Common Stock | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 15 Feb 2022 | 3,206 | 9,145 (0%) | 0% | 23.5 | 75,245 | Common Stock |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,623 | 7,217 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 14,558 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 0 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,573 | 6,573 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 7,010 | 31,582 (0%) | 0% | - | Common Shares | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 7,010 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 9,038 | 9,038 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,573 | 6,573 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,573 | 6,573 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 0 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 22,701 (0%) | 0% | - | Common Stock | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,573 | 6,573 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 14,558 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 6,573 | 6,573 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 0 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,098 | 14,097 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 31,428 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.74 per share. | 28 Dec 2021 | 31,428 | 105,054 (0%) | 0% | 30.7 | 966,097 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.28 per share. | 28 Dec 2021 | 31,428 | 73,626 (0%) | 0% | 32.3 | 1,014,496 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 30,473 | 31,428 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.74 per share. | 28 Dec 2021 | 30,473 | 104,099 (0%) | 0% | 30.7 | 936,740 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.01 per share. | 28 Dec 2021 | 30,473 | 73,626 (0%) | 0% | 32.0 | 975,441 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 23 Dec 2021 | 8,602 | 73,626 (0%) | 0% | 32 | 275,264 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 8,602 | 61,901 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.74 per share. | 23 Dec 2021 | 8,602 | 82,228 (0%) | 0% | 30.7 | 264,425 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 124,275 | 124,275 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 53,304 | 53,304 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 14,125 | 14,125 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 32,932 | 32,932 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 23,819 | 23,819 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 10,216 | 10,216 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 21,748 | 21,748 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 9,328 | 9,328 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 9,328 | 9,328 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 21,748 | 21,748 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 21,748 | 21,748 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 9,328 | 9,328 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 1,638 | 1,638 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.58 per share. | 13 Aug 2021 | 480 | 5,594 (0%) | 0% | 27.6 | 13,238 | Common Stock |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 1,638 | 6,074 (0%) | 0% | 0 | Common Stock | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 7,378 | 7,378 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 17,605 | 17,605 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.93 per share. | 14 May 2021 | 296 | 2,111 (0%) | 0% | 23.9 | 7,083 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 863 | 0 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 863 | 2,407 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 30 Apr 2021 | 2,970 | 3,363 (0%) | 0% | 24 | 71,280 | Common Stock |
| Ruediger Naumann-Etienne | Director | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 02 Mar 2021 | 4,264 | 24,572 (0%) | 0% | 23.9 | 101,867 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 18 Feb 2021 | 956 | 0 (0%) | 0% | 22.7 | 21,663 | Common Stock |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 11,523 | 11,523 | - | - | Restricted Stock Units | |
| Andrew Hartmann | SVP Sales & Marketing, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 28,195 | 28,195 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 67,822 | 67,822 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 9,363 | 66,352 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,092 | 73,444 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 8,374 | 81,818 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.50 per share. | 12 Feb 2021 | 11,137 | 70,681 (0%) | 0% | 23.5 | 261,720 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 165,950 | 165,950 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 9,363 | 0 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,092 | 7,092 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 8,374 | 16,748 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,104 | 6,676 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,397 | 8,073 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Feb 2021 | 1,890 | 6,183 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 11,523 | 11,523 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 28,195 | 28,195 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,307 | 0 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,104 | 1,105 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,397 | 2,794 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,307 | 5,572 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.50 per share. | 12 Feb 2021 | 1,996 | 43,375 (0%) | 0% | 23.5 | 46,906 | Common Stock |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 11,523 | 11,523 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 28,195 | 28,195 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,521 | 0 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,146 | 1,147 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,354 | 2,708 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,354 | 45,371 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,146 | 44,017 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,521 | 42,871 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 955 | 1,910 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 943 | 943 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 955 | 1,898 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.50 per share. | 12 Feb 2021 | 942 | 956 (0%) | 0% | 23.5 | 22,137 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 6,584 | 6,584 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 943 | 944 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,420 | 2,840 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.50 per share. | 12 Feb 2021 | 1,079 | 1,544 (0%) | 0% | 23.5 | 25,357 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 11,523 | 11,523 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,420 | 2,623 (0%) | 0% | - | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,203 | 1,203 (0%) | 0% | - | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 28,195 | 28,195 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,203 | 1,203 | - | - | Restricted Stock Units | |
| Christine A. Tsingos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,881 | 6,881 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 9,460 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 5,929 | 28,836 (0%) | 0% | - | Common Stock | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 5,929 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,462 | 9,462 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,881 | 6,881 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 3,603 | 0 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,881 | 6,881 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 3,603 | 17,603 (0%) | 0% | - | Common Stock | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,881 | 6,881 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 9,460 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 8,999 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,312 | 0 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 6,881 | 6,881 | - | - | Deferred Stock Units | |
| Timothy E. Guertin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 5,776 | 5,776 | - | - | Deferred Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 60,630 | 60,630 | - | - | Restricted Stock Units | |
| Shubham Maheshwari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 160,944 | 160,944 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 16.34 per share. | 20 Jul 2020 | 1,629 | 0 (0%) | 0% | 16.3 | 26,618 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 862 | 863 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.52 per share. | 15 May 2020 | 298 | 564 (0%) | 0% | 17.5 | 5,221 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 862 | 862 (0%) | 0% | - | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Sale of securities on an exchange or to another person at price $ 17.96 per share. | 15 May 2020 | 564 | 0 (0%) | 0% | 18.0 | 10,129 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 173,206 | 173,206 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 60,446 | 60,446 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 29,147 | 29,147 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 10,172 | 10,172 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 28,026 | 28,026 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 9,780 | 9,780 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 5,868 | 5,868 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 29,428 | 29,428 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 10,269 | 10,269 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 2,008 | 26,395 (0%) | 0% | 25.9 | 51,987 | Common Stock |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 2,149 | 6,447 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,820 | 3,640 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 2,149 | 28,403 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,820 | 26,254 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 2,413 | 24,434 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 2,413 | 2,414 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 11,075 | 56,145 (0%) | 0% | 25.9 | 286,732 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 9,363 | 51,754 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 7,092 | 58,846 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 8,374 | 67,220 (0%) | 0% | 0 | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 9,363 | 9,363 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 8,374 | 25,122 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 7,092 | 14,184 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,307 | 1,307 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,307 | 3,413 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,104 | 4,517 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,396 | 5,913 (0%) | 0% | 0 | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 1,862 | 4,051 (0%) | 0% | 25.9 | 48,207 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,104 | 2,208 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,396 | 4,191 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,147 | 2,293 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 1,958 | 40,502 (0%) | 0% | 25.9 | 50,693 | Common Stock |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,354 | 42,460 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,147 | 41,106 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,520 | 39,959 (0%) | 0% | 0 | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,354 | 4,062 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,520 | 1,521 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 1,609 | 1,629 (0%) | 0% | 25.9 | 41,657 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,341 | 1,341 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 943 | 2,284 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 954 | 3,238 (0%) | 0% | 0 | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,341 | 0 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 943 | 1,887 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 954 | 2,865 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,420 | 4,260 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,203 | 2,406 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 14 Feb 2020 | 1,553 | 0 (0%) | 0% | 25.3 | 39,275 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 14 Feb 2020 | 1,070 | 1,553 (0%) | 0% | 25.9 | 27,702 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,420 | 2,623 (0%) | 0% | 0 | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2020 | 1,203 | 1,203 (0%) | 0% | 0 | Common Stock | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 5,148 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 6,160 | 6,160 | - | - | Deferred Stock Units | |
| Christine A. Tsingos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 7,078 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 8,471 | 8,471 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 7,078 | 22,907 (0%) | 0% | - | Common Shares | |
| Walter M. Rosebrough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 6,160 | 6,160 | - | - | Deferred Stock Units | |
| Erich R Reinhardt | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.89 per share. | 13 Feb 2020 | 138 | 18,085 (0%) | 0% | 25.9 | 3,573 | Common Stock |
| Erich R Reinhardt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 18,223 (0%) | 0% | - | Common Stock | |
| Erich R Reinhardt | Director | Sale of securities on an exchange or to another person at price $ 25.91 per share. | 13 Feb 2020 | 15,074 | 13,075 (0%) | 0% | 25.9 | 390,567 | Common Stock |
| Erich R Reinhardt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 0 | - | - | Deferred Stock Units | |
| Erich R Reinhardt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 15,074 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Erich R Reinhardt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.24 per share. | 13 Feb 2020 | 15,074 | 28,149 (0%) | 0% | 23.2 | 350,320 | Common Stock |
| Erich R Reinhardt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 6,160 | 6,160 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 6,160 | 6,160 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 0 | - | - | Deferred Stock Units | |
| Jay K. Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 5,148 | 5,148 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 4,687 | 4,687 (0%) | 0% | - | Common Stock | |
| Jocelyn D. Chertoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2020 | 4,687 | 0 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2020 | 6,160 | 6,160 | - | - | Deferred Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.84 per share. | 01 Nov 2019 | 13,530 | 51,969 (0%) | 0% | 22.8 | 309,025 | Common Stock |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Sale of securities on an exchange or to another person at price $ 31.02 per share. | 01 Nov 2019 | 13,530 | 38,439 (0%) | 0% | 31.0 | 419,701 | Common Stock |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2019 | 13,530 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2019 | 21,047 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Clarence Verhoef | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.94 per share. | 16 Oct 2019 | 21,047 | 21,951 (0%) | 0% | 28.9 | 609,100 | Common Stock |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.84 per share. | 16 Oct 2019 | 21,047 | 42,998 (0%) | 0% | 22.8 | 480,713 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 15 Jul 2019 | 1,149 | 0 (0%) | 0% | 31 | 35,619 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 30.56 per share. | 05 Jul 2019 | 268 | 1,149 (0%) | 0% | 30.6 | 8,190 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 26 Jun 2019 | 916 | 2,039 (0%) | 0% | 30 | 27,480 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2019 | 863 | 863 (0%) | 0% | - | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2019 | 863 | 1,725 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 15 May 2019 | 572 | 0 (0%) | 0% | 28.7 | 16,388 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.16 per share. | 15 May 2019 | 291 | 572 (0%) | 0% | 29.2 | 8,486 | Common Stock |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,820 | 23,177 (0%) | 0% | - | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 26,507 | 26,507 | - | - | Non-Qualified Stock Option (right to buy) | |
| Clarence Verhoef | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 8,596 | 8,596 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,820 | 5,460 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,413 | 4,827 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,871 | 0 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 2,127 | 21,050 (0%) | 0% | 31.4 | 66,830 | Common Stock |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,871 | 18,944 (0%) | 0% | - | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,413 | 21,357 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 103,282 | 103,282 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,756 | 33,511 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 9,363 | 42,874 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 7,091 | 49,965 (0%) | 0% | - | Common Stock | |
| Sunny S. Sanyal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 8,566 | 41,399 (0%) | 0% | 31.4 | 269,144 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 2,756 | 0 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 9,363 | 18,726 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 7,091 | 21,276 | - | - | Restricted Stock Units | |
| Sunny S. Sanyal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 33,496 | 33,496 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,104 | 3,312 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 5,587 | 5,587 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 17,229 | 17,229 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,105 | 2,158 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,307 | 3,465 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,104 | 4,569 (0%) | 0% | - | Common Stock | |
| Kimberley E. Honeysett | SVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 1,692 | 2,877 (0%) | 0% | 31.4 | 53,163 | Common Stock |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,105 | 0 | - | - | Restricted Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,307 | 2,614 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,146 | 39,567 (0%) | 0% | - | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,520 | 38,421 (0%) | 0% | - | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,767 | 36,901 (0%) | 0% | - | Common Stock | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 16,699 | 16,699 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 5,416 | 5,416 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,146 | 3,440 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,520 | 3,041 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,767 | 0 | - | - | Restricted Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 2,067 | 37,500 (0%) | 0% | 31.4 | 64,945 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,341 | 1,341 (0%) | 0% | - | Common Stock | |
| Kevin B Yankton | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 1,135 | 1,149 (0%) | 0% | 31.4 | 35,662 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,341 | 1,341 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 943 | 2,830 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 3,819 | 3,819 | - | - | Restricted Stock Units | |
| Kevin B Yankton | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 943 | 2,284 (0%) | 0% | - | Common Stock | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 15 Feb 2019 | 492 | 710 (0%) | 0% | 31.4 | 15,459 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 5,680 | 5,680 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 17,516 | 17,516 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Sale of securities on an exchange or to another person at price $ 31.53 per share. | 15 Feb 2019 | 710 | 0 (0%) | 0% | 31.5 | 22,386 | Common Stock |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,202 | 3,609 | - | - | Restricted Stock Units | |
| Brian Giambattista | SVP and GM, X-ray Detectors | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2019 | 1,202 | 1,202 (0%) | 0% | - | Common Stock | |
| Christine A. Tsingos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 5,098 | 5,098 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 7,010 | 7,010 | - | - | Deferred Stock Units | |
| Walter M. Rosebrough | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 5,098 | 5,098 | - | - | Deferred Stock Units | |
| Erich R Reinhardt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 5,098 | 5,098 | - | - | Restricted Stock Units | |
| Jay K. Kunkel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 5,098 | 5,098 | - | - | Deferred Stock Units | |
| Jocelyn D. Chertoff | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2019 | 5,098 | 5,098 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2019 | 6,358 | 0 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2019 | 6,358 | 15,829 (0%) | 0% | - | Common Stock | |
| Erich R Reinhardt | None | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.42 per share. | 12 Feb 2019 | 1,272 | 13,075 (0%) | 0% | 31.4 | 39,966 | Common Stock |
| Erich R Reinhardt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2019 | 6,358 | 14,347 (0%) | 0% | - | Common Stock | |
| Erich R Reinhardt | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2019 | 6,358 | 0 | - | - | Deferred Stock Units | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2018 | 11,155 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mark S Jonaitis | SVP and GM, X-Ray Sources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.21 per share. | 14 Sep 2018 | 11,155 | 34,789 (0%) | 0% | 19.2 | 214,288 | Common Stock |
| Clarence Verhoef | SVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 29.58 per share. | 17 Aug 2018 | 3,300 | 15,925 (0%) | 0% | 29.6 | 97,614 | Common Stock |
| Sunny S. Sanyal | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 28.18 per share. | 10 Aug 2018 | 7,000 | 30,755 (0%) | 0% | 28.2 | 197,260 | Common Stock |
| Walter M. Rosebrough | None | Purchase of securities on an exchange or from another person at price $ 28.39 per share. | 07 Aug 2018 | 10,000 | 14,000 (0%) | 0% | 28.4 | 283,900 | Common Shares |
| Brian Giambattista | SVP and GM, X-ray Detectors | Sale of securities on an exchange or to another person at price $ 36.66 per share. | 02 Jul 2018 | 570 | 0 (0%) | 0% | 36.7 | 20,895 | Common Shares |
| Carl E. LaCasce | SVP, Sales & Marketing | Sale of securities on an exchange or to another person at price $ 37.42 per share. | 05 Jun 2018 | 11,155 | 16,816 (0%) | 0% | 37.4 | 417,400 | Common Stock |
| Carl E. LaCasce | SVP, Sales & Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2018 | 11,155 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Carl E. LaCasce | SVP, Sales & Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.21 per share. | 05 Jun 2018 | 11,155 | 27,971 (0%) | 0% | 19.2 | 214,288 | Common Stock |
| Ruediger Naumann-Etienne | None | Sale of securities on an exchange or to another person at price $ 37.96 per share. | 30 May 2018 | 1,500 | 9,471 (0%) | 0% | 38.0 | 56,942 | Common Stock |
| Kevin B Yankton | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 37.00 per share. | 14 May 2018 | 862 | 0 (0%) | 0% | 37 | 31,894 | Common Stock |
| Walter M. Rosebrough | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2018 | 3,603 | 3,603 | - | - | Deferred Stock Units | |
| Kimberley E. Honeysett | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 37.68 per share. | 16 Apr 2018 | 2,000 | 916 (0%) | 0% | 37.7 | 75,352 | Common Stock |
| Christine A. Tsingos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 4,312 | 4,312 | - | - | Deferred Stock Units | |
| Ruediger Naumann-Etienne | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 5,929 | 5,929 | - | - | Deferred Stock Units | |
| Erich R Reinhardt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 4,312 | 4,312 | - | - | Deferred Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 22,871 | 22,871 | - | - | Non-Qualified Stock Option (right to buy) | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 2,413 | 7,240 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 2,870 | 2,871 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 1,809 | 0 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 7,280 | 7,280 | - | - | Restricted Stock Units | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 2,413 | 9,413 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 2,870 | 12,283 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2018 | 1,809 | 14,092 (0%) | 0% | 0 | Common Stock | |
| Clarence Verhoef | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.10 per share. | 15 Feb 2018 | 2,138 | 11,954 (0%) | 0% | 37.1 | 79,320 | Common Stock |